Drugs / TIV
last change Dec 2017 re-read 3 minutes ago

TIV

Vaccine

Developed for
influenza
Investigated by
Folia Biotech Inc.

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02188810 Apr 2014 → Dec 2017 influenza Folia Biotech Inc. Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT02188810 ↗
Modality Vaccine “seasonal flu vaccine (Fluviral)” NCT02188810 ↗
Route Intramuscular “Single dose administered intramuscularly .” NCT02188810 ↗